An Australian trial which used a marijuana extract to treat 40 children with severe epilepsy found the drug has a manageable side effect profile, but only shows extensive symptom relief for a select number of patients. Following treatment with cannabidiol, a non-psychoactive compound found in marijuana, about one in five were described as much or very much improved from their baseline, while around half reported none, or a very slight improvement. “This was a statewide…
No comments:
Post a Comment